Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SQ109 early bactericidal activity study in pulmonary tuberculosis
PACTR201009000252144Recruiting
- Sponsor
- LMU Klinikum
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of SQ109 and rifampicin in Tuberculosis (TB) and pulmonary tuberculosis (TB) (5 arms), sponsored by LMU Klinikum. Started Nov 2010; status: recruiting.
02
Drugs
SQ109rifampicin
03
Conditions
Tuberculosis (TB)pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201009000252144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201009000252144.